Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain-Reference-Cited by-同舟云学术

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

Published:2005-03 Issue:2-3 Volume:73 Page:147-152
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Reynolds Lindsay M.,Cochran Susan M.,Morris Brian J.,Pratt Judith A.,Reynolds Gavin P.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference38 articles.

1. Sub-chronic PCP administration significantly alters parvalbumin-immunoreactive interneurones in the prefrontal cortex and hippocampus of the rat;Abdul-Monim;Br. Neurosci. Assoc. Abstr.,2003

2. Phencylidine-induced psychosis;Allen;Am. J. Psychiatry,1978

3. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics;Anderson;Schizophr. Res.,1997

4. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics;Beasley;Schizophr. Res.,1997

5. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study;Bertolino;Biol. Psychiatry,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamatergic dysfunction in Schizophrenia;Translational Psychiatry;2022-12-03

2. Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?;Schizophrenia Research;2020-12

3. Striatal N-Acetylaspartate Synthetase Shati/Nat8l Regulates Depression-Like Behaviors via mGluR3-Mediated Serotonergic Suppression in Mice;International Journal of Neuropsychopharmacology;2017-08-31

4. Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine;Journal of Psychopharmacology;2016-09-27

5. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology;European Neuropsychopharmacology;2016-01